Nyxoah (NYXH) Cash from Operations Growth (1y) (2022 - 2026)
Nyxoah (NYXH) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -28.74% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.99% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -15.62% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 262.94% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 34.32% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 90.02% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -4.50% |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.97% |
| Mar 31, 2026 | 29.55% |
| Dec 31, 2025 | -984.41% |
| Sep 30, 2025 | 817.93% |
| Jun 30, 2025 | -57.46% |
| Mar 31, 2025 | 45.34% |
| Dec 31, 2024 | 84.10% |
| Sep 30, 2024 | -124.27% |
| Jun 30, 2024 | -6.41% |
| Mar 31, 2024 | 16.50% |
| Dec 31, 2023 | -692.14% |
| Sep 30, 2023 | 792.50% |
| Jun 30, 2023 | -122.33% |
| Mar 31, 2023 | 85.80% |
| Dec 31, 2022 | -10.71% |
| Sep 30, 2022 | 71.89% |
| Jun 30, 2022 | -208.66% |
| Mar 31, 2022 | 226.03% |